|
- 2016
姜黄素对人子宫内膜癌细胞HEC-1-B侵袭转移的影响
|
Abstract:
摘要:目的 研究姜黄素对人子宫内膜癌细胞HEC-1-B侵袭转移的影响及其可能的机制。方法 不同浓度(0、10、20、30μmol/L)的姜黄素处理HEC-1-B细胞后,MTT法检测其对HEC-1-B细胞的生长抑制作用;体外Transwell小室实验检测姜黄素和/(或)PDTC对HEC-1-B细胞迁移和侵袭能力的影响;Western blot检测姜黄素对MMP-2、MMP-9表达、活性以及p65、p50蛋白水平的影响。结果 体外实验结果显示,姜黄素明显抑制子宫内膜癌细胞的生长、迁移及侵袭,且其作用呈时间-剂量依赖关系,其差异具有统计学意义(P<0.001)。此外,姜黄素处理HEC-1-B细胞24h后,细胞中MMP-2、MMP-9的表达、蛋白酶活性及P65、P50水平均明显减弱。单独使用姜黄素、PDTC组均可抑制其侵袭力,两者联合用药后对癌细胞侵袭能力的抑制效应较单独使用更明显,且明显下调MMP-2、MMP-9的表达,从而进一步拮抗HEC-1-B细胞的粘附和侵袭。结论 姜黄素通过抑制上游核转录因子κB(NF-κB)活性而下调MMP-2和MMP-9的表达,进而抑制人子宫内膜癌HEC-1-B细胞的侵袭和转移。因此,姜黄素是一种潜在的子宫内膜癌治疗剂。
ABSTRACT: Objective To investigate the effects and possible mechanisms of curcumin on invasion and metastasis in endometrial carcinoma HEC-1-B cells. Methods HEC-1-B cells were cultured in vitro and treated with 0, 10, 20 and 30μmol/L of curcumin. MTT assay was performed to examine cell growth; then cell invasion assay using Transwell chamber was used to evaluate the effects of curcumin/PDTC on invasion of HEC-1-B cells. The expression and activity of matrix metalloproteinases MMP-2, MMP-9 as well as the protein levels of P65 and P50 were analyzed by Western blot. Results Compared with control group, curcumin could significantly inhibit the invasion and migration abilities of HEC-1-B cells in vitro in concentration and time-dependent manners. In addition, mechanism and functional analysis revealed that the administration of curcumin decreased the expression and activity of the extracellular matrix (ECM) factors MMP-2 and MMP-9, and the protein levels of P65 and P50, which was attributed to the suppression of anti-invasion effect produced by curcumin. Furthermore, 10μmol/L curcumin or 20μmol/L PDTC alone could produce similary inhibitory effect on the invasion of HEC-1-B cells. Combination of curcumin and PDTC could significantly enhance the suppressive effect, which was associated with downregulation of MMP-2/MMP-9. Conclusion These findings suggest a potential mechanism by which curcumin blocks NF-κB activity to downregulate the expression of MMP-2/MMP-9 and then inhibit the invasion and metastasis of endometrial cancer cells, suggesting that curcumin is a potent therapeutic agent for endometrial carcinoma
[1] | MITRA A, CHAKRABARTI J, BANERJI A, et al. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2[J]. J Environ Pathol Toxicol Oncol, 2006, 25(4):679-690. |
[2] | SUN W, LIU DB, LI WW, et al. Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9 [J]. Int J Oncol, 2014, 44(5):1551-1560. |
[3] | LI J, LAU GK, CHEN L, et al. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression[J]. PLoS One, 2011, 6(7):e21816. |
[4] | CHUN KS, KEUM YS, HAN SS, et al. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation[J]. Carcinogenesis, 2003, 24(9):1515-1524. |
[5] | DUARTE VM, HAN E, VEENA MS, et al. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NF kappaB pathway[J]. Mol Cancer Ther, 2010, 9(10):2665-2675. |
[6] | SOROSKY JI. Endometrial cancer[J]. Obstet Gynecol, 2008, 111(2 Pt 1):436-447. |
[7] | STEWART BW, WILD CP. International agency for research on cancer. World Cancer Report 2014[R]. World Health Organization. Chapter 5.12.ISBN 978-92-832-0429-9. |
[8] | CHEN J, WANG FL, CHEN WD. Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression[J]. Mol Biol Rep, 2014, 41(7):4583-4594. |
[9] | SANMUKHANI J, SATODIA V, TRIVEDI J, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial[J]. Phytother Res, 2014, 28(4):579-585. |
[10] | JIAO Y, WILKINSON JT, DI X, et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator [J]. Blood, |
[11] | 2009, 113(2):462-469. |
[12] | KITCHENER HC, TRIMBLE EL. Endometrial cancer state of the science meeting[J]. Int J Gynecol Cancer, 2009, 19(1):134-140. |
[13] | HSU CH, CHENG AL.Clinical studies with curcumin[J]. Adv Exp Med Biol, 2007, 595(1):471-480. |
[14] | CHEN K, ZHANG S, JI Y, et al. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway[J]. PLoS One, 2013, 8(9):e72927. |
[15] | HOFFMAN B, SCHORGE J, SCHAFFER J, et al. Williams Gynecology (2nd ed.)[M]. McGraw-Hill, 2012:818. |
[16] | NAKSURIYA O, OKONOGI S, SCHIFFELERS RM, et al. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment [J]. Biomaterials, 2014, 35(10):3365-3383. |
[17] | 王箴. 化工辞典[M]. 第4版. 北京:化学工业出版社, 2001:459. |
[18] | ODOT J, ALBERT P, CARLIER A, et al. ??In vitro?? and ??in vivo?? anti-tumoral effect of curcumin against melanoma cells [J]. Int J Cancer, 2004, 111(3):381-387. |
[19] | LIANG YJ, HAO Q, WU YZ, et al. Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth[J]. Int J Gynecol Cancer, 2009, 19(7):1248-1252. |
[20] | YU Z, SHAH DM. Curcumin down-regulates Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A cells [J]. Gynecol Oncol, 2007, 106(3):541-548. |
[21] | BANERJI A, CHAKRABARTI J, MITRA A, et al. Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells[J]. Cancer Lett, 2004, 211(4):235-242. |
[22] | 喻芳,方唯意,邢福祺. 子宫内膜癌中基质金属蛋白酶-9表达及其临床意义[J]. 中国实用妇科与产科杂志, 2012, 28(2):144-145. |
[23] | TSAI KD, LIN JC, YANG SM, et al. Curcumin protects against UVB-induced skin cancers in SKH-1 hairless mouse: Analysis of early molecular markers in carcinogenesis[J]. Evid Based Complement Alternat Med, 2012, 12(5):593952. |
[24] | ZONG H, WANG F, FAN QX, et al. Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways[J]. Mol Biol Rep, 2012, 39(4):4803-4808. |
[25] | BOONRAO M, YODKEEREE S, AMPASAVATE C, et al. The inhibitory effect of turmeric curcuminoids on matrix metalloproteinase-3 secretion in human invasive breast carcinoma cells[J]. Arch Pharm Res, 2010, 33(7):989-998. |